Psychometric Validation of the Fatigue Symptoms and Impacts Questionnaire–Relapsing Multiple Sclerosis (Fsiq-Rms™)

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.03.160
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pnd135 - Fatigue in Multiple Sclerosis: Assessing the Psychometric Properties of the Mfis-5 Questionnaire

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Explaining Fatigue in Multiple Sclerosis: Cross-Validation of a Biopsychosocial Model

Journal of Behavioral Medicine
PsychiatryMental HealthPsychology
2016English

Emerging Therapies for Relapsing Multiple Sclerosis

Archives of Neurology
2009English

Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis

Neurotherapeutics
NeurologyPharmacology
2017English

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis

Archives of Neurology
2009English

Cladribine for Highly Active Relapsing Multiple Sclerosis

Prescriber
Pharmacology
2018English

The Impact of Pain and Other Symptoms on Quality of Life in Women With Relapsing-Remitting Multiple Sclerosis

Journal of Neuroscience Nursing
EndocrineMedicalAutonomic SystemsSurgical NursingNeurologySurgery
2009English

002 Therapeutic Lag in Relapsing Multiple Sclerosis

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2019English

Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics

Archives of Neurology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy